Dual-responsive nanoscale ultrasound contrast agent as an oxidative stress amplifier for enhanced DNA damage in BRCA-proficient ovarian cancer

Dual-responsive nanoscale ultrasound contrast agent as an oxidative stress amplifier for enhanced DNA damage in BRCA-proficient ovarian cancer

PARP inhibitor (PARPi)-based synthetic lethal therapies have displayed limited benefits in BRCA-proficient ovarian cancer. To potentiate the application of PARPi, an ultrasound contrast agent OLA-NDs for delivery of the PARPi olaparib (OLA) was established for enhancing DNA damage by blocking DNA re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jialu Zhang, Xiaoxuan Wang, Lu Guo, Shan Xiao, Dong Meng, Mengmeng Shang, Xiao Sun, Dandan Shi, Yading Zhao, Rui Liu, Shuting Huang, Xinyu Zeng, Jie Li
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Materials Today Bio
Subjects:	Ovarian cancer Ultrasound-targeted microbubble destruction DNA damage Reactive oxygen species Mitochondrial dysfunction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590006425003217
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

pH-sensitive fibronectin nanogels combined with UTMD for anti-atherosclerosis treatment through anti-inflammatory and antioxidant effects
by: Mengjiao Zhang, et al.
Published: (2025-08-01)

Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy
by: Wu Y, et al.
Published: (2025-02-01)

Translational motions and radial oscillations of a polymer-coated microbubble in the focal cross-section of focused acoustic vortex
by: Qingqin Zou, et al.
Published: (2025-08-01)

Contrast-enhanced ultrasound as a valuable tool to detect minimal inflammation in RA patients in sustained remission
by: Joaquim Polido-Pereira, et al.
Published: (2024-12-01)

B-mode and contrast-enhanced ultrasonography for intestinal assessment in dogs: A review
by: Iago Martins Oliveira, et al.
Published: (2025-03-01)

RADIOTHERAPY IN MANAGEMENT OF BRCA-POSITIVE OVARIAN CANCER
by: T. V. Gorodnova, et al.
Published: (2017-09-01)

Contrast-enhanced ultrasonography combined with microbubbles for uterine disorders: Current trends and future perspectives
by: Jian Ding, et al.
Published: (2025-06-01)

Contrast-Enhanced Ultrasound in the Diagnosis of Ocular Pathology: Application Prospects
by: T. N. Kiseleva, et al.
Published: (2021-07-01)

Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imaging
by: James K. Tsuruta, et al.
Published: (2024-12-01)

Design and 3D-model of a dynamic bubble trap for cardiopulmonary bypass
by: A. P. Kuleshov, et al.
Published: (2022-01-01)

Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
by: Anna Sokolenko, et al.
Published: (2025-06-01)

Ovarian cancer and BRCA mutation genetic testing: the Brazilian reality
by: Dalila Cunha de Oliveira, et al.
Published: (2021-10-01)

Unveiling the power of mitochondrial transfer in cancer progression: a perspective in ovarian cancer
by: Caixia Wang, et al.
Published: (2024-11-01)

BRCA1 expression in ovarian cancer and its relationship with clinicopathological characteristics and prognosis
by: Chenxiang Pan, et al.
Published: (2025-06-01)

A systematic review on the association between ovarian and prostate cancer with <I>BRCA1</I> and <I>BRCA2</I> gene
by: Sarpparajan Chitra Veena, et al.
Published: (2023-01-01)

Ultrasound targeted microbubbles for theranostic applications in liver diseases: from molecular imaging to targeted therapy
by: Chujun Zhang, et al.
Published: (2025-12-01)

BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer
by: Heidelinde Fiegl, et al.
Published: (2024-11-01)

Contrast agents for ultrasound examination
by: S. V. Fomina, et al.
Published: (2011-12-01)

Progresses and clinical application of super-resolution ultrasound imaging: a narrative review
by: Jia-yi Gao, et al.
Published: (2025-06-01)

Effect of ultrasonic burst microbubbles on microwave coagulation hemostasis in a pig model of hepatic hemorrhage
by: Bibo Peng, et al.
Published: (2025-02-01)

Magnetic Field/Ultrasound-Responsive Fe<sub>3</sub>O<sub>4</sub> Microbubbles for Targeted Mechanical/Catalytic Removal of Bacterial Biofilms
by: Liang Lu, et al.
Published: (2024-11-01)

A RARE CASE OF MULTIPLE-PRIMARY CANCER IN A WOMAN WITH BRCA 1 GENE MUTATION: BRCA-ASSOCIATED OVARIAN CANCER AND LUNG CARCINOID TUMOR
by: A. О. Ivantsov, et al.
Published: (2018-03-01)

Case Report: Clinical impact of BRCA1 and BRIP1 vs. BRCA1 and BRCA2 germline double heterozygosity in ovarian cancer: a comparative case study
by: Limei Zheng, et al.
Published: (2025-07-01)

A novel mitochondrial autophagy and aging-related gene signature for predicting ovarian cancer
by: Hongyu Zhang, et al.
Published: (2025-06-01)

OVARIAN CANCER IN PATIENTS WITH BRCA1 5382insC MUTATION
by: А. B. Villert, et al.
Published: (2016-02-01)

Nervonic acid triggered ovarian inflammation by inducing mitochondrial oxidative stress to activate NLRP3/ IL-1β pathway
by: Xiangzhou Zeng, et al.
Published: (2025-07-01)

Estimating long-term overall survival with olaparib as maintenance therapy in patients with newly diagnosed advanced ovarian cancer with BRCA mutations
by: N. A. Avxentyev, et al.
Published: (2021-10-01)

Follicular metabolic dysfunction, oocyte aneuploidy and ovarian aging: a review
by: Die Wu, et al.
Published: (2025-03-01)

Bavachin enhances paclitaxel sensitivity in ovarian cancer cells through modulation of mitochondrial function and ER stress
by: Sang-Jin Lee, et al.
Published: (2025-12-01)

Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review
by: T. V. Gorodnova, et al.
Published: (2024-11-01)

Experimental approbation of a new ultrosound contrast agent based on sulfur geksafluoride in diagnostics of focal liver lesions of inflammatory genesis
by: S. V. Fomina, et al.
Published: (2017-04-01)

Experimental measurement of the size distribution of microbubbles prepared by reciprocating syringe technique
by: Zhengbin Pan, et al.
Published: (2024-11-01)

New insights into ovarian regression-related mitochondrial dysfunction in the late-laying period
by: Tiantian Gu, et al.
Published: (2025-04-01)

Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment
by: Ali Raza, et al.
Published: (2025-04-01)

Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment
by: Giovanni Luca Scaglione, et al.
Published: (2025-05-01)

Ivosidenib Confers BRCAness Phenotype and Synthetic Lethality to Poly (ADP-Ribose) Polymerase Inhibition in <i>BRCA1/2</i>-Proficient Cancer Cells
by: Danyang Zhou, et al.
Published: (2025-04-01)

Cyclone microbubble flotation for enhanced oil recovery from palm oil mill effluent
by: Le Van Tuan
Published: (2025-06-01)

Ultrasound-activated poly(butyl cyanoacrylate) microbubbles enhance the therapeutic effect of Doxil
by: Julia Blöck, et al.
Published: (2025-09-01)

Advances of therapeutic microbubbles and nanobubbles
by: Huang Bin, et al.
Published: (2023-08-01)

Microbubble treatment of cinnamon leaves for enhancing the quality of mulled rice wine
by: Ping-Hao Huang, et al.
Published: (2025-12-01)